Management of stage II cervical carcinoma: Clinical guidelines

Research output: Contribution to journalArticle

Abstract

Stage IIB cervical carcinoma is a lesion intermediate between IB (lesion limited to the cervix uteri) and stage IIIB (lesion extending to the pelvic side wall). While stage IB is well defined - lesion limited to the cervix, and IIIB is also well defined - parametral involvement extending to the pelvic side wall, stage IIB is not that obvious. Parametral involvement is usually imagined by clinicians as a spread of the tumor beyond the cervix through a direct, continuous, centrifugal involvement of the lateral parametria (the cardinal ligament) towards the pelvic side wall. Here emphasis is on the so called "continuous spread". However, discontinuous spread of the cancer cells to the parametrion does occur, which is almost always microscopic and can only be diagnosed histologically. Also. early continuous spread is difficult to recognized by clinical means. Treatment options include chemoradiation, which is the most commonly used approach. A novel surgical intervention called laterally extended parametrectomy (LEP) is a valid alternative to chemoirradiation. Details of this procedures as well as pros and cons are discussed.

Original languageEnglish
Pages (from-to)58-62
Number of pages5
JournalCME Journal of Gynecologic Oncology
Volume15
Issue number1
Publication statusPublished - 2010

Fingerprint

Cervix Uteri
Guidelines
Carcinoma
Peritoneum
Ligaments
Neoplasms

Keywords

  • Cervical cancer
  • Chemoirradiation
  • Diagnosis
  • Laterally extended parametrectomy (LEP)
  • Spread
  • Stage IIB
  • Surgery

ASJC Scopus subject areas

  • Obstetrics and Gynaecology
  • Oncology

Cite this

Management of stage II cervical carcinoma : Clinical guidelines. / Pálfalvi, L.

In: CME Journal of Gynecologic Oncology, Vol. 15, No. 1, 2010, p. 58-62.

Research output: Contribution to journalArticle

@article{990c93d2a6204887b263ed897ca77069,
title = "Management of stage II cervical carcinoma: Clinical guidelines",
abstract = "Stage IIB cervical carcinoma is a lesion intermediate between IB (lesion limited to the cervix uteri) and stage IIIB (lesion extending to the pelvic side wall). While stage IB is well defined - lesion limited to the cervix, and IIIB is also well defined - parametral involvement extending to the pelvic side wall, stage IIB is not that obvious. Parametral involvement is usually imagined by clinicians as a spread of the tumor beyond the cervix through a direct, continuous, centrifugal involvement of the lateral parametria (the cardinal ligament) towards the pelvic side wall. Here emphasis is on the so called {"}continuous spread{"}. However, discontinuous spread of the cancer cells to the parametrion does occur, which is almost always microscopic and can only be diagnosed histologically. Also. early continuous spread is difficult to recognized by clinical means. Treatment options include chemoradiation, which is the most commonly used approach. A novel surgical intervention called laterally extended parametrectomy (LEP) is a valid alternative to chemoirradiation. Details of this procedures as well as pros and cons are discussed.",
keywords = "Cervical cancer, Chemoirradiation, Diagnosis, Laterally extended parametrectomy (LEP), Spread, Stage IIB, Surgery",
author = "L. P{\'a}lfalvi",
year = "2010",
language = "English",
volume = "15",
pages = "58--62",
journal = "CME Journal of Gynecologic Oncology",
issn = "1219-9087",
publisher = "Primed-X Press",
number = "1",

}

TY - JOUR

T1 - Management of stage II cervical carcinoma

T2 - Clinical guidelines

AU - Pálfalvi, L.

PY - 2010

Y1 - 2010

N2 - Stage IIB cervical carcinoma is a lesion intermediate between IB (lesion limited to the cervix uteri) and stage IIIB (lesion extending to the pelvic side wall). While stage IB is well defined - lesion limited to the cervix, and IIIB is also well defined - parametral involvement extending to the pelvic side wall, stage IIB is not that obvious. Parametral involvement is usually imagined by clinicians as a spread of the tumor beyond the cervix through a direct, continuous, centrifugal involvement of the lateral parametria (the cardinal ligament) towards the pelvic side wall. Here emphasis is on the so called "continuous spread". However, discontinuous spread of the cancer cells to the parametrion does occur, which is almost always microscopic and can only be diagnosed histologically. Also. early continuous spread is difficult to recognized by clinical means. Treatment options include chemoradiation, which is the most commonly used approach. A novel surgical intervention called laterally extended parametrectomy (LEP) is a valid alternative to chemoirradiation. Details of this procedures as well as pros and cons are discussed.

AB - Stage IIB cervical carcinoma is a lesion intermediate between IB (lesion limited to the cervix uteri) and stage IIIB (lesion extending to the pelvic side wall). While stage IB is well defined - lesion limited to the cervix, and IIIB is also well defined - parametral involvement extending to the pelvic side wall, stage IIB is not that obvious. Parametral involvement is usually imagined by clinicians as a spread of the tumor beyond the cervix through a direct, continuous, centrifugal involvement of the lateral parametria (the cardinal ligament) towards the pelvic side wall. Here emphasis is on the so called "continuous spread". However, discontinuous spread of the cancer cells to the parametrion does occur, which is almost always microscopic and can only be diagnosed histologically. Also. early continuous spread is difficult to recognized by clinical means. Treatment options include chemoradiation, which is the most commonly used approach. A novel surgical intervention called laterally extended parametrectomy (LEP) is a valid alternative to chemoirradiation. Details of this procedures as well as pros and cons are discussed.

KW - Cervical cancer

KW - Chemoirradiation

KW - Diagnosis

KW - Laterally extended parametrectomy (LEP)

KW - Spread

KW - Stage IIB

KW - Surgery

UR - http://www.scopus.com/inward/record.url?scp=84871633006&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84871633006&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:84871633006

VL - 15

SP - 58

EP - 62

JO - CME Journal of Gynecologic Oncology

JF - CME Journal of Gynecologic Oncology

SN - 1219-9087

IS - 1

ER -